AKR1B10 and breast carcinoma: Our data exhibited that AKR1B10 was highly expressed (scored at 3) in 7 (21.9%) of 32 breast cancer tissues (Figure 3A), moderately expressed (scored at 2) in 5 (15.6%) cases, and expressed at a low level (scored at 1) in 9 (28.1%) cases.